[1] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南.临床肝胆病杂志,2015,31:1752-1769. [2] Yu YC, Mao YM, Chen CW,et al.CSH guidelines for the diagnosis and treatment of drug-induced liver injury.Hepatol Int, 2017,11:221-241. [3] EASL 2018 国际肝病大会在法国巴黎盛大开幕[N/OL].2018-04-11.http://news.medlive.cn/liver/inf0-progress/show-141280_35 html. [4] Wang YY,Li J,Wu ZR,et al. Insights into the molecular mechanisms of polygonum multiflorum Thunb-induced liver injury:a computational systems toxicology approach.Acta Pharmacol Sin,2017,38:719-732. [5] Chalasani NP,Hayashi PH,Bonkovsky HL,et.al.ACG Clinical Guideline:the diagnosis and management of idosyncratic drug induced liver injury.Am J Gastroenterol, 2014,109:950-966. [6] Lewis JH.Drug-induced liver.Med Clin North Am,2000,84:1275-1311. [7] 李璇,刘红建,旷南岳.2012-2016年某三甲医院807例药品不良反应报告分析.安徽医药,2018,22:385-388. [8] 赵智峰,任利霞.1318例药品不良反应报告.中国医院用药评估与分析,2017,6:1705-1707,1710. [9] Katarey D,Verma S. Drug-induced liver injury.Clin Med,2016,16:104-109. [10] Yeo W,Mo FK,Chan SL,et al.Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy.Hepatology,2007,45:1382-1389. [11] Reuben A, Koch DG, Lee WM, Drug-induced acute liver failure: results of a US multicenter, prospective study.Hepatology, 2010. 52: 2065-2076. [12] Wang K,Zhang S,Marzolf B,et al. Circulating microRNAs,potential biomarkers for druginduced liver injury.Proc Natl Acad Sci USA,2009,106:4402-4407. |